FLAGSTAFF, Ariz., May 1, 2019 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that Pestec, an industry leader in environmentally conscious Integrated Pest Management (IPM) solutions, has added ContraPest® to their IPM programs for use in popular locations within the San Francisco Bay Area.
"San Francisco is a hub of culture, commerce and biodiversity," said Luis Agurto, President and CEO of Pestec. "The conditions that drive this vibrancy are the same conditons that drive all life, including rats. Our challenge as protectors of public health and property and being stewards of the environment is to find the right balance. We are very excited to deploy new innovative measures that protect people and pets and minimize the potential for unintended consequences to the environment."
Pestec plans to implement ContraPest® in historically rodent challenging locations within the city. These areas contain an abundance of sought after resources which make favorable conditions for rats and their reproduction. By utilizing ContraPest®, Pestec aims to control rat populations in a sustainable and long-term fashion for their clients. One of these clients, Recology at Pier 96, is a resource recovery recycling facility which aims to minimize the amount of waste within San Francisco.
"Our client's primary concern is protecting the health and safety to their staff and meeting their quality control requirements," continued Agurto. "However, businesses love when they have the option to choose better pest management outcomes AND less harm to the environment. Our partners at Recology are ecstatic with the new avian residents at Pier 96. Since transitioning from 2nd generation anti-coagulants (SGARs) several years ago, a pair of raptors moved in to do their part in the pest management effort. Now with a new option for reduced-risk rat management, our team has more assurance that rat populations won't rebound and our avian helpers aren't at risk of secondary poisoning."
"SenesTech is gratified that Pestec has adopted ContraPest® as a tool to humanely and effectively manage rat populations within the Bay Area. SenesTech works with numerous wildlife and environmental groups that aim to limit the amount of toxins in the environment. Pestec's forward thinking rodent management programs offer solutions that environmentally conscious clients such as these desire. San Francisco was one of the first cities in California to recognize the hazards of second generation anti-coagulants (SGARs), and one of the first cities to pass legislation to limit or eliminate SGARs. Now, they will also be leading the way in implementing innovative ways of controlling pests with less reliance on SGARs. As native Californians, we are very proud to be of service to our home state. A state that has committed themselves to environmental stewardship, wildlife, and smart growth cities," said Co-Founders, Dr. Cheryl Dyer, Chief Research Officer, and Dr. Loretta Mayer, CEO.
SenesTech is changing the paradigm of pest management by targeting the root cause of the problem: reproduction.
ContraPest® is an innovative technology with an approach that targets the reproductive capabilities of both sexes in rat populations, inducing egg loss in female rats and impairing sperm development in males. Using a proprietary bait delivery method, ContraPest® is dispensed in a highly palatable liquid formulation that promotes sustained consumption by rat communities. ContraPest® is designed, formulated and dispensed to be low hazard for handlers and non-target species such as wildlife, livestock and pets, where the active ingredients break down rapidly.
We believe ContraPest® will establish a new paradigm in rodent control, resulting in a decreased reliance on lethal options. For more information visit the SenesTech website at www.senestech.com.
Safe Harbor Statement
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors and other risks identified in our filings with the Securities and Exchange Commission. Forward looking statements include, but are not limited to, our expectation regarding sales commitments, our expectation regarding the conversion of sales commitments and programs to revenue, our belief that our product is more humane, less harmful to the environment and more effective than traditional methods, and our belief that ContraPest will establish a new paradigm in rodent control without environmental effects of rodenticides. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.
Investor: Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC, 602-889-9700, email@example.com
Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143
SOURCE SenesTech, Inc.